BB

Baker Brothers Advisors LLC

North America, New York, United States, New York

Description

Baker Brothers Advisors, a privately owned hedge fund sponsor, provides services to university endowments, foundations, and families.

Investor Profile

Baker Brothers Advisors LLC has made 24 investments, with 0 in the past 12 months and 17% as lead.

Stage Focus

  • Series C (21%)
  • Series B (17%)
  • Series Unknown (17%)
  • Post Ipo Equity (13%)
  • Series D (13%)
  • Series E (8%)
  • Series F (8%)
  • Post Ipo Secondary (4%)

Country Focus

  • United States (75%)
  • Canada (17%)
  • France (4%)
  • Bermuda (4%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Health Care
  • Medical
  • Clinical Trials
  • Biopharma
  • Health Diagnostics
  • Oncology
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Baker Brothers Advisors LLC frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 2
OrbiMed
North America, New York, United States, New York
Co-Investments: 3
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 4
Ventures West
North America, British Columbia, Canada, Vancouver
Co-Investments: 3
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 4
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 3
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Deerfield
North America, New York, United States, New York
Co-Investments: 2
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 2
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 3

What are some of recent deals done by Baker Brothers Advisors LLC?

DBV Technologies

Bagneux, Ile-de-France, France

DBV Technologies focuses on the development of innovative products for the diagnosis and treatment of food allergies.

BiopharmaBiotechnologyHealth CareHealth Diagnostics
Post Ipo EquityJun 9, 2022
Amount Raised: $192,213,954
FORMA Therapeutics

Watertown, Massachusetts, United States

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

BiotechnologyHealth CarePharmaceutical
Series DDec 19, 2019
Amount Raised: $100,000,000
IGM Biosciences

Mountain View, California, United States

IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.

BiotechnologyMedicalTherapeutics
Series CJul 8, 2019
Amount Raised: $102,000,000
Hookipa Pharma

New York, New York, United States

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

BiotechnologyClinical TrialsOncologyTherapeutics
Series DFeb 26, 2019
Amount Raised: $37,400,000
Cabaletta Bio

Philadelphia, Pennsylvania, United States

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

BiotechnologyHealth CareMedicalRoboticsTherapeutics
Series BJan 3, 2019
Amount Raised: $50,000,000
Omniox

San Carlos, California, United States

Omniox, a biotechnology company, commercializes technologies used in identifying and treating cancer, cardiovascular disease and trauma.

BiotechnologyHealth DiagnosticsTherapeutics
Series DMar 23, 2018
Kiniksa Pharmaceuticals

Hamilton, Hamilton, Bermuda

Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.

BiopharmaBiotechnologyMedical
Series CFeb 1, 2018
Amount Raised: $200,000,000
Hookipa Pharma

New York, New York, United States

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

BiotechnologyClinical TrialsOncologyTherapeutics
Series CDec 11, 2017
Amount Raised: $60,000,000
Principia Biopharma

South San Francisco, California, United States

Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.

BiopharmaBiotechnologyLife ScienceOncology
Series BAug 10, 2015
Amount Raised: $15,300,000
aTyr Pharma

San Diego, California, United States

aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics.

BiotechnologyPharmaceuticalTherapeutics
Series EMar 31, 2015
Amount Raised: $76,000,000